Background illustration for clinical trials search

Paid Clinical Trials Rockville

Discover 2,411 paid clinical trials in Rockville, Maryland. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 2,411

Samples From Human Subjects to Facilitate Basic, Translational and Clinical Research

for

Endothelial Dysfunction,

Location: Bethesda MD

Sponsor: National Institutes of Health Clinical Center (CC)

Sex: All

Age: 18 - 70+

Code: NCT03253705

Recruiting

Lenacapavir Intensification to Disrupt HIV Reservoirs in Virologically Suppressed People With HIV Receiving Antiretroviral Therapy

for

Human Immunodeficiency Virus

Location: Bethesda MD

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Sex: All

Age: 18 - 70+

Code: NCT06819176

Phase1, Recruiting

A Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular Lymphoma Patients

for

Untreated Follicular Lymphoma

Location: Bethesda MD, New York NY, New Haven CT, Albany NY,

Sponsor: AstraZeneca

Sex: All

Age: 18 - 70+

Code: NCT06549595

Phase3, Recruiting

Assessment of [18F]-Fluorocellobiose ([18F]FCB) Pharmacokinetics in Healthy Volunteers and Subjects With Invasive Mold Infections

for

Aspergillos, Mucormye, Dimorphic, Other Molds, Non-Aspergillos,

Location: Bethesda MD

Sponsor: National Institutes of Health Clinical Center (CC)

Sex: All

Age: 18 - 70+

Code: NCT07704333

Phase1, Recruiting

Fibrotic Disease Activity in Cardiopulmonary Disorders Using 18F-Fibroblast Activation Protein Inhibitor (18F-FAPI-74) PET/CT Imaging

for

Allogeneic Stem Cell Transplantation,

Location: Bethesda MD

Sponsor: National Heart, Lung, and Blood Institute (NHLBI)

Sex: All

Age: 18 - 70+

Code: NCT07613099

Phase3, Recruiting

PET Imaging of Noradrenergic Transmission in the Brain

for

Healthy

Location: Bethesda MD

Sponsor: National Institute of Mental Health (NIMH)

Sex: All

Age: 18 - 70+

Code: NCT07686393

Phase1, Recruiting

Ketoconazole Effects on the Daily Cortisol Rhythm in Mild Autonomous Cortisol Secretion

for

Mild Autonomous Cortisol Secretion

Location: Bethesda MD

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Sex: All

Age: 18 - 70+

Code: NCT07649317

Phase1, Recruiting

Escalating Doses of VAS-101 in Subjects With Stable Sickle Cell Disease

for

Sickle Cell Disease, Hemolytic Anemia

Location: Bethesda MD

Sponsor: National Heart, Lung, and Blood Institute (NHLBI)

Sex: All

Age: 18 - 70+

Code: NCT07566494

Phase1, Recruiting

Natural History Study to Determine Drug Metabolism Phenotype and Appropriate Germline Source DNA in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant

for

Leukemia, Lymphoma, Hematologic Malignancy

Location: Bethesda MD

Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18 - 70+

Code: NCT06856226

Recruiting

Hepatic Lipid Metabolism-Alcohol Use Disorder

for

Alcohol Use Disorder

Location: Bethesda MD

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Sex: All

Age: 18 - 70+

Code: NCT07191561

Recruiting

Evaluate the Efficacy and Safety of Ruxolitinib on Hair Regrowth in Patients With Autoimmune Polyendocrinopathy Candidiasis Ectodermal Dystrophy (APECED)-Associated Alopecia Areata

for

Autoimmune Polyendocrinopathy Candidiasis Ectodermal Dystrophy (Apeced),

Location: Bethesda MD

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Sex: All

Age: 12 - 70+

Code: NCT05398809

Phase2, Recruiting

Open-label Study of SKY-GJB2 in Pediatric Subjects With GJB2-mediated Hearing Loss

for

GJB2-mediated Hearing Loss, GJB2 Gene Mutation, DFNB1A

Location: Bethesda MD, Allentown PA, Boston MA, Oklahoma City OK

Sponsor: Skylark Bio Inc.

Sex: All

Age: 0 - 7

Code: NCT07627971

Phase1, Phase2, Recruiting

Partial Stem Cell Transplant for Sickle Cell Disease From Matched Donors

for

Sickle Cell Disease, Beta-thalassemia

Location: Bethesda MD

Sponsor: National Heart, Lung, and Blood Institute (NHLBI)

Sex: All

Age: 4 - 65

Code: NCT07599176

Phase1, Phase2, Recruiting

Tirzepatide s Dopaminergic Effects in Alcohol Use Disorders (AUD)

for

Alcohol Use Disorder (AUD)

Location: Bethesda MD

Sponsor: National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Sex: All

Age: 21 - 65

Code: NCT07559500

Phase1, Recruiting

PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI)

for

Alzheimer s Disease, Mild Cognitive Impairment, Healthy

Location: Bethesda MD

Sponsor: National Institute of Mental Health (NIMH)

Sex: All

Age: 50 - 70+

Code: NCT07169630

Phase1, Recruiting

Desmopressin Stimulation Test Performance in ACTH-Dependent Cushing Syndrome

for

Cushing Syndrome

Location: Bethesda MD

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Sex: All

Age: 18 - 70

Code: NCT06635629

Phase2, Recruiting

Assessment of 11C-JMJ-129 for Imaging PDE4D in Brain and Whole Body of Healthy Volunteers

for

Healthy

Location: Bethesda MD

Sponsor: National Institute of Mental Health (NIMH)

Sex: All

Age: 18 - 70+

Code: NCT06874205

Phase1, Recruiting

[18F]PF-06445974 to Image PDE4B in Major Depressive Disorder Using PET

for

Depression

Location: Bethesda MD

Sponsor: National Institute of Mental Health (NIMH)

Sex: All

Age: 18 - 70

Code: NCT05703685

Phase1, Recruiting

GRAfT 2.0. A Multimodal Prospective Approach to Define the Mechanisms and Clinical Features of Acute and Chronic Rejection in Lung Transplantation

for

Lung Transplant, End Stage Lung Disease, Rejection

Location: Bethesda MD

Sponsor: National Heart, Lung, and Blood Institute (NHLBI)

Sex: All

Age: 18 - 70+

Code: NCT07516379

Recruiting

Intravenous Brincidofovir as an Antiviral for Treatment of Progressive Multifocal Leukoencephalopathy: A Pilot Study

for

Progressive Multifocal Leukoencephalopathy

Location: Bethesda MD

Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)

Sex: All

Age: 18 - 70+

Code: NCT07511049

Phase2, Recruiting

Paid Clinical Trials Rockville

Filter results

Samples From Human Subjects to Facilitate Basic, Translational and Clinical Research

Lenacapavir Intensification to Disrupt HIV Reservoirs in Virologically Suppressed People With HIV Receiving Antiretroviral Therapy

A Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular Lymphoma Patients

Assessment of [18F]-Fluorocellobiose ([18F]FCB) Pharmacokinetics in Healthy Volunteers and Subjects With Invasive Mold Infections

Fibrotic Disease Activity in Cardiopulmonary Disorders Using 18F-Fibroblast Activation Protein Inhibitor (18F-FAPI-74) PET/CT Imaging

Interested in new trials?

PET Imaging of Noradrenergic Transmission in the Brain

Ketoconazole Effects on the Daily Cortisol Rhythm in Mild Autonomous Cortisol Secretion

Escalating Doses of VAS-101 in Subjects With Stable Sickle Cell Disease

Natural History Study to Determine Drug Metabolism Phenotype and Appropriate Germline Source DNA in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant

Hepatic Lipid Metabolism-Alcohol Use Disorder

Evaluate the Efficacy and Safety of Ruxolitinib on Hair Regrowth in Patients With Autoimmune Polyendocrinopathy Candidiasis Ectodermal Dystrophy (APECED)-Associated Alopecia Areata

Open-label Study of SKY-GJB2 in Pediatric Subjects With GJB2-mediated Hearing Loss

Partial Stem Cell Transplant for Sickle Cell Disease From Matched Donors

Tirzepatide s Dopaminergic Effects in Alcohol Use Disorders (AUD)

PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI)

Desmopressin Stimulation Test Performance in ACTH-Dependent Cushing Syndrome

Assessment of 11C-JMJ-129 for Imaging PDE4D in Brain and Whole Body of Healthy Volunteers

[18F]PF-06445974 to Image PDE4B in Major Depressive Disorder Using PET

GRAfT 2.0. A Multimodal Prospective Approach to Define the Mechanisms and Clinical Features of Acute and Chronic Rejection in Lung Transplantation

Intravenous Brincidofovir as an Antiviral for Treatment of Progressive Multifocal Leukoencephalopathy: A Pilot Study